TP53 and cancer: Furthermore, CDCA proteins interact with other cell cycle regulators and signaling pathways implicated in cancer progression, such as the p53 tumor suppressor pathway and the PI3K/AKT/mTOR pathway, thereby amplifying their oncogenic effects [63, 64].